- Home
- » Tags
- » Desmopressin
Top View
- Desmopressin for the Treatment of Adult Nocturia
- AVPR2 Variants and V2 Vasopressin Receptor Function in Nephrogenic Diabetes Insipidus
- Hyponatremia
- Desmopressin Nasal Spray Solution, USP 0.01%
- Information Leaflet for Primary Care: Noqdirna (Desmopressin Oral Lyophilisate)
- Oral Pharmaceutical Desmopressin Composition
- Antiproliferative Effects of Oxytocin and Desmopressin on Canine Mammary Cancer Cells
- Guidelines for the Assessment and Management of Hyponatraemia
- Tolvaptan for Treatment of Iatrogenic Hyponatremia
- Lithium-Induced Diabetes Insipidus: Prevention and Management
- Product Monograph
- DDAVP® Melt Product Monograph
- United States Patent (19) 11 Patent Number: 5,763,405 Fjellestad-Paulsen Et Al
- Synthetic Peptides by Dr Olga Kolaj-Robin
- Assessment Report
- A Simple Strategy for Safe Correction of Severe Hyponatremia
- Vasopressin Using ALZET Osmotic Pumps
- Tranexamic Acid Versus Carbetocin for Reduction of Blood Loss During Abdominal Myomectomy: a Randomized Clinical Trial
- Management of Severe Hyponatremia: Infusion of Hypertonic Saline and Desmopressin Or Infusion of Vasopressin Inhibitors? Antonios H
- Efficiency of Single Dose of Tolvaptan Treatment During the Triphasic Episode After Surgery for Craniopharyngioma
- Desmopressin PH&T, Nasal Sapray
- Application for Inclusion of a Medicine in the WHO Model List of Essential Medicines
- NOCTIVA (Desmopressin Acetate) Nasal Spray, for Intranasal Use (4) Initial U.S
- Tolvaptan C21091-A
- The Effect of Neurohypophyseal Peptides on the Intraocular Pressure and Pupil of the Rabbit Jason David Horowitz Yale University
- Valine-279 Deletion–Mutation on Arginine Vasopressin Receptor 2
- Tolvaptan Plus Pasireotide Shows Enhanced Efficacy in a PKD1 Model
- Table S1: Clinical Trials of AVP Antagonists and Agonists
- Peptide Hormone Receptors Product Listing | Edition 2
- Characterization of Five Novel Vasopressin V2 Receptor Mutants
- The Oxytocin Receptor Signalling System and Breast Cancer: a Critical Review
- Auspar Attachment 1: Product Information for Desmopressin
- Fluid and Hyponatremia Management
- Desmopressin Increases IGF-Binding Protein-1 in Humans
- Jynarque Samsca Tolvaptan
- The Role of the Desmopressin Test in the Diagnosis and Follow-Up Of
- Desmopressin Acetate) Rx Only
- Desmopressin-PH&T, Nasal Spray Solution
- Appendix C - Guidelines for IV Medication Administration
- Pharmaceutical Compositions Including Low Dosages of Desmopressin
- Hinchcliffe, JK, Mendl, M., & Robinson, ESJ (2020). Investigating
- Of 5 Clinical Policy: Desmopressin Acetate (DDAVP, Stimate)
- DESMOPRESSIN ACETATE TABLETS, 0.1 Mg and 0.2 Mg 7316 7317 Rx Only
- SAMSCA (Tolvaptan) Is Available in 15 Mg and 30 Mg Tablets [See How Supplied/Storage and Handling (16)]
- DESMOPRESSIN (DDAVP) in the TREATMENT of BLEEDING DISORDERS Revised Edition
- DDAVP (Desmopressin) in the Dental Management Patients with Mild Or Moderate Hemophilia and Von Willebrand’S Disease
- Use of Tetracycline for the Manufacture of a Medicament for Lowering the Intraocular Pressure
- Desmopressin Acetate (DDAVP) for Diabetes Insipidus